NorthWest Biotherapeutics Inc (NWBO)

[gnawkz]

Pyrr,

My understanding was that NWBO's manufacturing process was significantly different from current industry standards.

Current industry standards rely on a biochemical factor known as IL-4 to prevent Dendritic Cells from maturing into undesirable cell types. This maturation "pivot" causes the Dendritic Cell confused state.

NWBO has developed and recently obtained the patent for a new DC manufacturing that significantly decreases the confused state.

http://www.prnewswire.com/news-releases/nw-bio-receives-us-patent-on-broad-processes-for-producing-more-potent-dendritic-cells-198760831.html

Other studies that use DC vaccines should be plagued by the above issues, but I am not sure if those same issues apply to NWBO's DCVax programs. Due to the differences in manufacturing processes, it is not possible to compare NWBO's DC Vaccine with competitor DC Vaccines.

Let me know if I understood the above patent incorrectly.

Thanks